One of the key issues that is anticipated to constrain the Autism Spectrum Disorder Therapeutics Market is the lack of specialists qualified to appropriately diagnose ASD. For instance, there are only 8,300 child psychiatrists, 1,500 child neurologists, and 1,000 developmental-behavioral paediatricians for the more than 1 million autistic children in the United States as of 2018, according to study from the Simons Foundation Autism Research Initiative (SFARI).
Also, an earlier ASD diagnosis might benefit a child's growth. For instance, reliable ASD diagnosis is possible sooner than 18 months old, and there may be possibilities to assess the value of ASD treatment at a young age, according to study published in the journal JAMA Pediatrics in April 2019.
Read More:
https://bloggerstrive.blogspot.com/2023/03/autism-spectrum-disorder-therapeutics.html
Facebook Conversations